Study of First Parkinson's Disease Vaccine Shows Encouraging Results

(August 6, 2014) - AFFiRiS AG announced results of AFF008, a Phase I clinical trial of PD01A, a vaccine against Parkinson's disease. PD01A is the first therapy against the protein alpha-synuclein, a promising Parkinson's drug target, to enter clinical testing. Read more…

Click for a printer friendly version